The scientists at BSRC “Alexander Fleming” perform cutting-edge research, aiming to understand molecular mechanisms of complex biological processes in health and disease. We are also committed to contribute to innovation in medicine, by developing novel therapeutic and diagnostic methods, focusing on immunity and inflammation, cancer, and neurodegenerative diseases. To keep our focus on top-notch research, we recruit at all levels with excellence as the sole criterion and we support our researchers by providing state-of-the science infrastructures and a pleasant working environment. FLEMING is a non-profit organization operating under the auspices of the Greek General Secretariat for Research & Technology and is supported by the Greek government and by national, European and international grants.

Highlights

18/06/2018
18 June 2018

The Inauguration of the "Center for New Biotechnologies & Precision Medicine" was announced at a press conference held on 07.06.2018 at the University of Athens. Fleming is a key collaborating Institute in this initiative and partner of pMedGR, the Greek Research Infrastructure for Personalised Medicine, which forms the basis of the New Center.

06/06/2018
06 June 2018

In a recent study published in PNAS, PhD student Ana Henriques from the labs of Dr. George Kollias and Dr. Vasiliki Koliaraki revealed that the kinase MK2 through the activation of Hsp27 in intestinal mesenchymal cells/CAFs plays an essential role in the promotion of colorectal cancers. [Pubmed].

09/05/2018
09 May 2018

Expanding previous work on the role of autotaxin in chronic inflammatory disorders that has provided the scientific basis for phase IIb clinical trials in idiopathic pulmonary fibrosis, Fleming researchers have now uncovered a role for this secreted lysophospholipase D in the pathogenesis of lung cancer [PubMed].

16/04/2018
16 April 2018

Fleming researchers, using a Spondyloarthritis (SpA) mouse model have found that Tnfr2 signaling is regulating polyarthritis and a newly identified heart valve stenosis, which is a common comorbidity of SpA in human patients. [PubMed], [JCI Highlight].

NEWS AND EVENTS

23/07/2018

Seminar 23/07/2018, 13:00. "Big Data Analysis and Genetic Liability to Neuropsychiatric Disease", Assoc. Prof. Panagiotis Roussos, Icahn Institute for Genomics and Multiscale Biology and Friedman Brain Institute, N. York.

PUBLICATIONS

Visit BSRC Fleming's scientific Publications web page

FUNDING

Visit BSRC Fleming's funding web page

WebMail

For internal users

INTRANET

For internal users

B.S.R.C. "Alexander Fleming"
34 Fleming Street, 16672 Vari, Greece
Contact us